Description
ALK translocation as therapeutic marker for Lung Cancer
ALK translocation as therapeutic marker for Lung Cancer
₹640.85 Original price was: ₹640.85.₹0.00Current price is: ₹0.00.
ALK translocation as therapeutic marker for Lung Cancer
ALK translocation as therapeutic marker for Lung Cancer
5-HIAA
5-HIAA
Susceptibily results with MIC values of Linezolid, Trimethoprim / Sulphamethaxole, Ciprofloxacin, Imipenem, Moxifloxacin, Cefepime, Cefoxitin, Augmentin, Amikacin, Ceftriaxone, Doxycycline, Minocycline, Tigecycline, Tobramycin, Clarithromycin
Susceptibily results with MIC values of Linezolid, Trimethoprim / Sulphamethaxole, Ciprofloxacin, Imipenem, Moxifloxacin, Cefepime, Cefoxitin, Augmentin, Amikacin, Ceftriaxone, Doxycycline, Minocycline, Tigecycline, Tobramycin, Clarithromycin
APTT measures intrinsic and common pathways of the coagulation cascade. Prolonged APTT may be caused by heparin and other anticoagulants, factor deficiencies or inhibitors such as lupus anticoagulants
APTT measures intrinsic and common pathways of the coagulation cascade. Prolonged APTT may be caused by heparin and other anticoagulants, factor deficiencies or inhibitors such as lupus anticoagulants

Reviews
There are no reviews yet.